At Rush University Medical Center, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.


French German Italian Portuguese Russian

Rotator Cuff Stem Cell Clinical Trial

Clinical Trial Title: 
Rotator cuff stem cell clinical trial.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Brian J. Cole, MD, MBA; Anthony A. Romeo, MD; Nikhil N. Verma, MD
Clinical Trial Protocol Description: 

The primary objective of this study is to compare the clinical outcomes of arthroscopic rotator cuff repair with and without augmentation of mesenchymal stem cells (MSCs). Mesenchymal stem cells promote tissue regeneration by differentiating into adult cell lines and by supplying growth factors to their implanted environment. They have been shown to be effective in improving both overall healing and tendon integrity in rotator cuff repair. This study will follow 100 patients in the United States and track their clinical outcomes for at least one year post-operatively.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Have shoulder pain.
  • Be between ages 18 and 70.
  • Be willing to undergo initial evaluation and imaging to determine if your pain is caused by rotator cuff injury.
  • Be a candidate for surgical rotator cuff repair.

This is a partial list of elgibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Clinical Trial Area: 
Orthopedic Conditions
Contact Phone: 
(312) 361-2104
Contact Name: 
Midwest Orthopaedics